Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030

This document presents the major issues that were discussed in the process of working towards the development of a new medicines policy in Saudi Arabia, examining current national practice in light of international practices and experiences. The do...

Full description

Bibliographic Details
Main Authors:	Alghaith, Taghred, Almoteiry, Khalid, Alamri, Adwa, Alluhidan, Mohammed, Alharf, Adel, Al-Hammad, Bander, Aliafali, Ibrahim, Seiter, Andreas, Pisani, Elizabeth, Herbst, Christopher H., El-Saharty, Sameh, Alazemi, Nahar
Format:	Working Paper
Language:	English
Published:	World Bank, Washington, DC 2021
Subjects:	PHARMACEUTICAL SYSTEM MEDICINE POLICY ACCESS TO HEALTH CARE MEDICINE PRICING PHARMACEUTICAL INDUSTRY
Online Access:	http://documents.worldbank.org/curated/en/305991624017831749/Strengthening-the-Pharmaceutical-System-in-the-Kingdom-of-Saudi-Arabia-Towards-a-Medicine-Policy-to-Support-Vision-2030 http://hdl.handle.net/10986/35846

id	okr-10986-35846
recordtype	oai_dc
spelling	okr-10986-358462021-06-29T05:11:41Z Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030 Alghaith, Taghred Almoteiry, Khalid Alamri, Adwa Alluhidan, Mohammed Alharf, Adel Al-Hammad, Bander Aliafali, Ibrahim Seiter, Andreas Pisani, Elizabeth Herbst, Christopher H. El-Saharty, Sameh Alazemi, Nahar PHARMACEUTICAL SYSTEM MEDICINE POLICY ACCESS TO HEALTH CARE MEDICINE PRICING PHARMACEUTICAL INDUSTRY This document presents the major issues that were discussed in the process of working towards the development of a new medicines policy in Saudi Arabia, examining current national practice in light of international practices and experiences. The document is designed to foster discussion and help inform the development of a new national medicine policy. A detailed accounting of the evidence informing policy choices to be highlighted in an updated medicine policy are presented in Part I of this discussion paper; a proposed new National Medicine Policy itself is presented in Part ll. A new Medicine policy, once finalized and approved, will need to be implemented in a highly dynamic environment and must therefore allow for flexibility. It will need to be followed by the implementation of regulations, closely monitored, and adapted as necessary over time. 2021-06-28T21:00:02Z 2021-06-28T21:00:02Z 2020 Working Paper http://documents.worldbank.org/curated/en/305991624017831749/Strengthening-the-Pharmaceutical-System-in-the-Kingdom-of-Saudi-Arabia-Towards-a-Medicine-Policy-to-Support-Vision-2030 http://hdl.handle.net/10986/35846 English Health, Nutrition and Population Discussion Paper; CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank World Bank, Washington, DC Publications & Research Publications & Research :: Working Paper Middle East and North Africa Saudi Arabia
repository_type	Digital Repository
institution_category	Foreign Institution
institution	Digital Repositories
building	World Bank Open Knowledge Repository
collection	World Bank
language	English
topic	PHARMACEUTICAL SYSTEM MEDICINE POLICY ACCESS TO HEALTH CARE MEDICINE PRICING PHARMACEUTICAL INDUSTRY
spellingShingle	PHARMACEUTICAL SYSTEM MEDICINE POLICY ACCESS TO HEALTH CARE MEDICINE PRICING PHARMACEUTICAL INDUSTRY Alghaith, Taghred Almoteiry, Khalid Alamri, Adwa Alluhidan, Mohammed Alharf, Adel Al-Hammad, Bander Aliafali, Ibrahim Seiter, Andreas Pisani, Elizabeth Herbst, Christopher H. El-Saharty, Sameh Alazemi, Nahar Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030
geographic_facet	Middle East and North Africa Saudi Arabia
relation	Health, Nutrition and Population Discussion Paper;
description	This document presents the major issues that were discussed in the process of working towards the development of a new medicines policy in Saudi Arabia, examining current national practice in light of international practices and experiences. The document is designed to foster discussion and help inform the development of a new national medicine policy. A detailed accounting of the evidence informing policy choices to be highlighted in an updated medicine policy are presented in Part I of this discussion paper; a proposed new National Medicine Policy itself is presented in Part ll. A new Medicine policy, once finalized and approved, will need to be implemented in a highly dynamic environment and must therefore allow for flexibility. It will need to be followed by the implementation of regulations, closely monitored, and adapted as necessary over time.
format	Working Paper
author	Alghaith, Taghred Almoteiry, Khalid Alamri, Adwa Alluhidan, Mohammed Alharf, Adel Al-Hammad, Bander Aliafali, Ibrahim Seiter, Andreas Pisani, Elizabeth Herbst, Christopher H. El-Saharty, Sameh Alazemi, Nahar
author_facet	Alghaith, Taghred Almoteiry, Khalid Alamri, Adwa Alluhidan, Mohammed Alharf, Adel Al-Hammad, Bander Aliafali, Ibrahim Seiter, Andreas Pisani, Elizabeth Herbst, Christopher H. El-Saharty, Sameh Alazemi, Nahar
author_sort	Alghaith, Taghred
title	Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030
title_short	Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030
title_full	Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030
title_fullStr	Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030
title_full_unstemmed	Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030
title_sort	strengthening the pharmaceutical system in the kingdom of saudi arabia : towards a medicine policy to support vision 2030
publisher	World Bank, Washington, DC
publishDate	2021
url	http://documents.worldbank.org/curated/en/305991624017831749/Strengthening-the-Pharmaceutical-System-in-the-Kingdom-of-Saudi-Arabia-Towards-a-Medicine-Policy-to-Support-Vision-2030 http://hdl.handle.net/10986/35846
_version_	1764483895444635648

Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030

Similar Items